Falcon Therapeutics Inc is a biotechnology company focused on developing brain cancer treatments. Employing autologous, tumor-homing neural stems cells that destroy cancer cells, the company uses these cells to create personalized genetically engineered neural stem cells to treat the cancer. The company's stem cell therapies represent an entirely new approach to Glioblastoma therapy tusing tumor-homing stem cells technology and create personalized genetically engineered neural stem cells therapies from the skin of cancer patients, enabling them to recover Glioblastoma -- the most common form of primary brain cancer.
